The Bioactive Compounds in Medicinal Mushrooms have Potential Protective Effects against Neurodegenerative Diseases

Crossmark: check for updates

Authors

  • Tongtong Xu Center for Plant and Mushroom Foods for Health, Department of Food Science, The Penn- sylvania State University, University Park, PA 16802, USA
  • Robert B. Beelman Center for Plant and Mushroom, Foods for Health, 404 Rodney A. Erickson Food Science Building, University Park, PA 16802, USA

DOI:

https://doi.org/10.17140/aftnsoj-1-110

Keywords:

Neurodegenerative Diseases, Mushrooms, Neurite, Bioactive Compounds, Anti-oxidative effects

Abstract

The Comprehensive and Alternative Medicine (CAM) to treat Neurodegenerative Diseases (NDs) has attracted attention from healthcare professionals and scientific researchers recently. Although in its early research stage, a good number of studies have been performed to investigate the potential preventive or even therapeutic effects of some medicinal mushrooms on NDs. We reviewed recent scientific publications reporting the extraction and identification of the bioactive compounds in medicinal mushrooms commonly used in Asian countries for their potential protective effects against NDs. Five medicinal mushrooms - Hericium erinaceus, Termitomyces albuminosus, Ganoderma lucidum, Dictyophora indusiata, Mycoleptodonoides aitchisonii- have been covered in this review. In vitro, in vivo, and clinical studies have been conducted to confirm the potential protective effects of these compounds against neurodegen-erative diseases. Because of the limited research, no clear mechanisms of the preventive ac-tions can be proposed. More animal and human studies are needed in the future to confirm the anti-neurodegenerative effects and understand the mechanism of the protective action of these bioactive compounds.

References

Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Current neuropharmacology. 2009; 7: 65. doi: 10.2174/157015909787602823

Mattila P, Konko K, Eurola M, et al. Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. Journal of Agricultural and Food Chemistry. 2001; 49: 2343-2348. doi: 10.1021/jf001525d

Mattila P, Salo-Vaananen P, Konko K, Aro H, Jalava T. Basic composition and amino acid contents of mushrooms cultivated in Finland. Journal of Agricultural and Food Chemistry. 2002; 50: 6419-6422. doi: 10.1021/jf020608m

Xu T, Beelman B, Lambert D. The cancer preventive effects of edible mushrooms. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2012; 12: 1255-1263. doi: 10.2174/187152012803833017

Phan CW, David P, Naidu M, Wong KH, Sabaratnam V. Therapeutic potential of culinary-medicinal mushrooms for the man-Journal agement of neurodegenerative diseases: diversity, metabolite, and mechanism. Critical reviews in biotechnology. 2014; 1-14. doi: 10.3109/07388551.2014.887649

Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial. Phytotherapy Research. 2009; 23: 367-372. doi: 10.1002/ptr.2634

Kawagishi H, Zhuang C, Yunoki R. Compounds for dementia from Hericium erinaceum. Drugs of the Future. 2008; 33: 149. doi: 10.1358/dof.2008.033.02.1173290

Nagai K, Chiba A, Nishino T, Kubota T, Kawagishi H. Dilinoleoyl-phosphatidylethanolamine from Hericium erinaceum protects against ER stress-dependent Neuro-2a cell death via protein kinase C pathway. The Journal of nutritional biochemistry. 2006; 17: 525-530. doi: 10.1016/j.jnutbio.2005.09.007

Qi J, Ojika M, Sakagami Y. Termitomycesphins A-D, novel neuritogenic cerebrosides from the edible Chinese mushroom Termitomyces albuminosus. Tetrahedron. 2000; 56: 5835-5841. doi: 10.1016/S0040-4020(00)00548-2

Qu Y, Sun K, Gao L, et al. Termitomycesphins G and H, additional cerebrosides from the edible Chinese mushroom Termitomyces albuminosus. Bioscience, biotechnology, and biochemistry. 2012; 76: 791-793. doi: 10.1271/bbb.110918

Choi JH, Maeda K, Nagai K, et al. Termitomycamides A to E, fatty acid amides isolated from the mushroom Termitomyces titanicus, suppress endoplasmic reticulum stress. Organic letters. 2010; 12: 5012-5015. doi: 10.1021/ol102186p

Weng Y, Lu J, Xiang L, et al. Ganodermasides C and D, two new anti-aging ergosterols from spores of the medicinal mushroom Ganoderma lucidum. Bioscience, biotechnology, and biochemistry. 2011; 75: 800-803. doi: 10.1271/bbb.100918

Weng Y, Xiang L, Matsuura A, Zhang Y, Huang Q, Qi J. Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene. Bioorganic & medicinal chemistry. 2010; 18: 999-1002. doi: 10.1016/j.bmc.2009.12.070

Zhang XQ, Ip FC, Zhang DM, et al. Triterpenoids with neurotrophic activity from Ganoderma lucidum. Natural product research. 2011; 25: 1607-1613. doi: 10.1080/14786419. 2010.496367

Kawagishi H, Ishiyama D, Mori H, et al. Dictyophorines A and B, two stimulators of NGF-synthesis from the mushroom Dictyophora indusiata. Phytochemistry. 1997; 45: 1203-1205. doi: 10.1016/S0031-9422(97)00144-1 ISSN 2377-8350 http://dx.doi.org/10.17140/AFTNSOJ-1-110 Open Journal

Lee IK, Yun BS, Han G, Cho DH, Kim YH, Yoo ID. Dictyoquinazols A, B, and C, new neuroprotective compounds from the mushroom Dictyophora indusiata. Journal of natural products. 2002; 65: 1769-1772. doi: 10.1021/np020163w

Choi JH, Horikawa M, Okumura H, et al. Endoplasmic reticulum (ER) stress protecting compounds from the mushroom Mycoleptodonoides aitchisonii. Tetrahedron. 2009; 65: 221-224. doi: 10.1016/j.tet.2008.10.068

Choi JH, Suzuki T, Okumura H, et al. Endoplasmic Reticulum Stress Suppressive Compounds from the Edible Mushroom Mycoleptodonoides aitchisonii. Journal of natural products. 2014; 77: 1729-1733. doi: 10.1021/np500075m

Dubost NJ, Ou B, Beelman RB. Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chem. 2007; 105: 727-735. doi: 10.1016/j.foodchem.2007.01.030

Weigand-Heller AJ, Kris-Etherton PM, Beelman RB. The bioavailability of ergothioneine from mushrooms (Agaricus bisporus) and the acute effects on antioxidant capacity and biomarkers of inflammation. Preventive medicine. 2012; 54: S75-S78. doi: 10.1016/j.ypmed.2011.12.028

Yang NC, Lin HC, Wu JH, et al. Ergothioneine protects against neuronal injury induced by β-amyloid in mice. Food and Chemical Toxicology. 2012; 50: 3902-3911. doi: 10.1016/j. fct.2012.08.021

Downloads

Published

2015-05-18

How to Cite

Tongtong Xu, & Robert B. Beelman. (2015). The Bioactive Compounds in Medicinal Mushrooms have Potential Protective Effects against Neurodegenerative Diseases. Advances in Food Technology and Nutrition Sciences, 1(2), 62–66. https://doi.org/10.17140/aftnsoj-1-110

Issue

Vol. 1 No. 2 (2015): Volume 1 Issue 2 2015

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Advances in Food Technology and Nutrition Sciences (AFTNS) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.